J Liver Cancer Search

CLOSE


Review Article

April 22, 2022


Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
Dong-Hyun Kim
J Liver Cancer. 2022;22(2):93-102.

Review Article

September 22, 2022


Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
Eun-Ji Choi, Young-Joon Kim
J Liver Cancer. 2022;22(2):103-114.

Original Article

May 20, 2022


The dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genes
Jeong Eun Yoo, Ji Hae Nahm, Young-Joo Kim, et al.
J Liver Cancer. 2022;22(2):115-124.

Original Article

June 28, 2022


Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
Young-Hwan Ahn, Heirim Lee, Ji Eun Han, et al.
J Liver Cancer. 2022;22(2):125-135.

Original Article

September 16, 2022


Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study
Jeong Yun Jang, Jinhong Jung, Danbi Lee, et al.
J Liver Cancer. 2022;22(2):136-145.

Original Article

September 14, 2022


Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study
Sung Jun Jo, Jinsoo Rhu, Jong Man Kim, et al.
J Liver Cancer. 2022;22(2):146-157.

Original Article

September 27, 2022


Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
Wonjoon Jang, Hye Won Lee, Jae Seung Lee, et al.
J Liver Cancer. 2022;22(2):158-166.

Original Article

September 29, 2022


The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis
Young Chang, Soung Won Jeong, Jae Young Jang, et al.
J Liver Cancer. 2022;22(2):167-177.

Current issue

Volume 22(2); September

Journal archive

Vol. 22
2022
v.22(1)
Mar 2022
v.22(2)
Sep 2022
Vol. 21
2021
v.21(1)
Mar 2021
v.21(2)
Sep 2021
Vol. 20
2020
v.20(1)
Mar 2020
v.20(2)
Sep 2020
Vol. 19
2019
v.19(1)
Mar 2019
v.19(2)
Sep 2019
Vol. 18
2018
v.18(1)
Mar 2018
v.18(2)
Sep 2018
Vol. 17
2017
v.17(1)
Mar 2017
v.17(2)
Sep 2017
Vol. 16
2016
v.16(1)
Mar 2016
v.16(2)
Sep 2016
Vol. 15
2015
v.15(1)
Mar 2015
v.15(2)
Sep 2015
Vol. 14
2014
v.14(2)
Sep 2014
Journal of the Korean Liver Cancer Study Group 2001 (Vol.1 No.1) to 2014 (Vol.14 No.1)
Vol. 14
2014
v.14(1)
Mar 2014
Vol. 13
2013
v.13(1)
Feb 2013
v.13(2)
Sep 2013
Vol. 12
2012
v.12(1)
Feb 2012
v.12(2)
Sep 2012
Vol. 11
2011
v.11(1)
Feb 2011
v.11(2)
Sep 2011
Vol. 10
2010
v.10(1)
Jun 2010
Vol. 9
2009
v.9(1)
Jun 2009
Vol. 8
2008
v.8(1)
Jun 2008
Vol. 7
2007
v.7(1)
Jun 2007
Vol. 6
2006
v.6(1)
Jun 2006
Vol. 5
2005
v.5(1)
Jun 2005
Vol. 4
2004
v.4(1)
Jun 2004
Vol. 3
2003
v.3(1)
Jul 2003
Vol. 2
2002
v.2(1)
Jul 2002
Vol. 1
2001
v.1(1)
Jun 2001
  • KoreaMed
  • KoMCI
  • GoogleScholar
  • DOAJ
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID

ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR AUTHORS AND REVIEWERS
Editorial Office
620 Yeoksam Heights Bldg.(FASTFIVE),151 Teheran-ro, Gangnam-gu, Seoul 06132, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2022 by The Korean Liver Cancer Association.

Developed in M2PI

Close layer
prev next
Close layer
prev next